| WOMEN HEALTH: - G & O: -Therapeutic dosages of oral or transdermal estradiol did not modify sCD40L levels in postmenopausal women |
Abstract The CD40/CD40L system is considered a crucial modulator of the inflammatory process underlying the progression and complication of atheroma plaques. The soluble fraction of CD40L (sCD40L) is a reliable indicator of the CD40/CD40L system. Our purpose was to investigate whether a therapeutic dose of estradiol, by either the oral or the transdermal route, was associated with changes in circulating levels of sCD40L. Forty-seven women completed a 4-week course of treatment with either oral estradiol valerate (2 mg/day, 20 women) or transdermal estradiol (50 μg/day, ... |
 |
 |
 |
NOTICIA SELECCIONADA POR E-MEDICUM |
 |
|
|
Director Médico